TSS
NUVB icon

Two Sigma Securities’s Nuvation Bio NUVB Stock Holding History

Two Sigma Securities’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-25,442
Closed -$109K – 2163
2026
Q1 		$109K Buy
+25,442
New +$142K 0.01% 1159
2025
Q4 		– Sell
-22,565
Closed -$83.5K – 1849
2025
Q3 		$83.5K Buy
+22,565
New +$61.5K 0.01% 930

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DFO
Duquesne Family Office New York $5.21B AUM 87.01% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Two Sigma Securities's NUVB Position: Q2 2026 in Review

Two Sigma Securities sold out of Nuvation Bio (NUVB) in Q2 2026, closing a stake of 25,442 shares — an estimated $109K sold.

Two Sigma Securities first reported a position in NUVB in Q3 2025 and held it in 2 quarters. The position peaked at $109K in Q1 2026. 244 funds tracked by Wall St. Rank hold NUVB as of Q2 2026.

  • Two Sigma Securities reported no remaining Nuvation Bio position as of Q2 2026 after selling out during the quarter.
  • Two Sigma Securities sold 25,442 Nuvation Bio shares in Q2 2026, an estimated $109K.
  • Two Sigma Securities first reported a position in Nuvation Bio in Q3 2025 and held it in 2 quarters.
  • Two Sigma Securities's Nuvation Bio position peaked at $109K in Q1 2026.
  • 244 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2026.

Based on Two Sigma Securities's 13F filing for Q2 2026, filed 14 Aug 2026.